ID   BHL-89
AC   CVCL_2306
DR   ECACC; 98070109
DR   Wikidata; Q54796445
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7672713;
CC   Doubling time: 48 hours (PubMed=7672713).
CC   Derived from site: In situ; Axillary lymph node; UBERON=UBERON_0001097.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
RX   PubMed=7672713;
RA   Palyi, Istvan
RA   Fleischmann, Tamas
RA   Palyi, Vilma
RA   Daubner, Dora
RA   Raposa, Tibor
RA   Paloczi, Katalin
RA   Benczur, Miklos
RA   Gergely, Lajos
RA   Csuka, Orsolya
RA   Bak, Mihaly
RT   "Establishment and characterization of an EBNA-negative human lymphoma
RT   cell line (BHL-89).";
RL   Haematologica 80:206-211(1995).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//